ALTA is a service-provider company specialized in developing and managing scientific research projects.

The mission of ALTA is to support research activities from the idea to the realization of project.

ALTA assists in finding the proper strategy, building European Consortia and putting science in the most appropriate administrative and management framework.

highlight The burden of CE in Eastern Europe (ultrasound surveys)

 

TLID

Prevalence of abdominal cystic echinococcosis in
rural Bulgaria, Romania
and Turkey

 

→ more




The Lancet Infectious Diseases
Volume 18 - Issue 7 - July 2018



© Elsevier Limited/Kouzou Sakai/FolioArt

 

The absence of CE from top-level peer review journals contributes to its neglect status. Here we present the first “original research” (no review, no case report) ever published on echinococcosis by The Lancet Infectious Diseases. Web link to the article:

The Lancet ID Article:
The burden of CE in Bulgaria, Romania, and Turkey

Comment to the Article:
Eliminating cystic echinococcosis in the 21st century

 

For further information, visit HERACLES website

iCARE-2 → 15 Mobility Fellowships

 

15 Mobility Fellowships for experienced researchers co-funded by AIRC and the European Union

 

iCARE-2 is an EU project coordinated by AIRC and supported by ALTA

 

For further information, visit iCARE-2 website

highlight PROJECTS APPROVED H2020-MSCA-COFUND-2017


Marie Sklodowska-Curie Actions Co-funding of regional,

national and international programmes

dot iCARE-2
  International Cancer Research Fellowships – 2
  (AIRC - Associazione Italiana per la Ricerca sul Cancro)

highlight PROJECTS APPROVED IN THE 2016-2017 CALL - HORIZON 2020


Health, demographic change and well-being

Personalised medicine - Clinical research on regenerative medicine

dot HIPGEN
  Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative
  therapy for improving recovery and survival following hip fracture
  arthroplasty ? HIPGEN, a multicenter phase III trial

  (Berlin-Brandenburg Center for Regenerative Therapies BCRT,
  Charit?-Universit?tsmedizin Berlin)


dot PACE
  A multicentre phase II study using HLA-unmatched allogeneic
  placenta-derived stromal cells (PLX-PAD) for the treatment of
  severe critical limb ischemia accompanied by mechanistic studies

  (Berlin-Brandenburg Center for Regenerative Therapies BCRT,
   Charit?-Universit?tsmedizin Berlin)



Health, demographic change and well-being

Personalised medicine ? New therapies for chronic diseases

dot LIVERHOPE
  Simvastatin and Rifaximin as new therapy for patients with
  decompensated cirrhosis

  (Hospital Clinic de Barcelona, Institut de Investigacions Biomediques
   August Pi i Sunyer)



Climate action, environment, resource efficiency and raw materials

dot 4PRIMA
  Partnership for Research and Innovation in the Mediterranean Area
  (Ministero dell'istruzione, dell'Università e della Ricerca)


MARIE SKLODOWSKA-CURIE ACTIONS

Innovative Training Networks (ITN) ? European Training Networks (ETN)


dot MarPipe
  Improving the flow in the pipeline of the next generation of marine
  biodiscovery scientists (Consiglio Nazionale delle Ricerche - Napoli)

find out more

Find out more open the link

highlight ISO 9001


Our company is in the process of planning, development and implementation of a quality management system in accordance with the standard UNI EN ISO 9001:2008



ALTA channels
ALTA on Linkedin ALTA on Facebook ALTA YouTube channel

Last update: May 27, 2021


February, 2021
GLYTUNES - A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis
Website online link

September, 2019
An important work resulting from the IMI ABIRISK project that ALTA managed.
The IRB identifies the Achilles heel of a therapeutic antibody for multiple sclerosis pdf
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients link

March, 2019
PANDORA is a success story
Safety of nanoparticles under scrutiny pdf
@MSCActions link

September, 2018
Neglected tropical diseases

New approach needed to tackle parasitic liver disease in Europe and Turkey → more

31 August 2018 | Geneva – A cross-sectional study conducted in Bulgaria, Romania and Turkey has found that the true burden of cystic echinococcosis is poorly understood and that many cases remain asymptomatic, with no appropriate medical diagnosis and treatment. The study assessed the prevalence of the disease among rural populations in the three countries.

New article on World Health Organization

For further information, please visit HERACLES website

June, 2018
HIPGEN website online

May, 2018
The burden of CE in Eastern Europe (ultrasound surveys)

Prevalence of abdominal cystic echinococcosis in rural Bulgaria, Romania and Turkey → more

The absence of CE from top-level peer review journals contributes to its neglect status. Here we present the first “original research” (no review, no case report) ever published on echinococcosis by The Lancet Infectious Diseases.

The Lancet ID Article:
The burden of CE in Bulgaria, Romania, and Turkey

Comment to the Article:
Eliminating cystic echinococcosis in the 21st century

For further information, please visit HERACLES website

May, 2018
15 Mobility Fellowships for experienced researchers co-funded by AIRC and the European Union

iCARE-2 is an EU project coordinated by AIRC ans supported by ALTA

For further information, please visit iCARE-2 website

PROJECT APPROVED IN THE H2020-MSCA-COFUND-2017

Marie Sklodowska-Curie Actions Co-funding of regional, national and international programmes:

dot iCARE-2
International Cancer Research Fellowships – 2
(AIRC - Associazione Italiana per la Ricerca sul Cancro)

PROJECTS APPROVED IN THE 2016-2017 CALL HORIZON 2020

Health, demographic change and well-being - Personalised medicine - Clinical research on regenerative medicine:

dot HIPGEN
Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative   therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial
(Berlin-Brandenburg Center for Regenerative Therapies BCRT, Charité-Universitätsmedizin Berlin)

dot PACE
A multicentre phase II study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies
(Berlin-Brandenburg Center for Regenerative Therapies BCRT, Charité-Universitätsmedizin Berlin)

Health, demographic change and well-being - Personalised medicine – New therapies for chronic diseases:

dot LIVERHOPE
Simvastatin and Rifaximin as new therapy for patients with decompensated cirrhosis (Hospital Clinic de Barcelona, Institut de Investigacions Biomediques August Pi i Sunyer)

Climate action, environment, resource efficiency and raw materials:

dot 4PRIMA
Partnership for Research and Innovation in the Mediterranean Area
(Ministero dell'istruzione, dell'Università e della Ricerca)

MARIE SKLODOWSKA-CURIE ACTIONS Innovative
Training Networks (ITN) ? European Training Networks (ETN):

dot MarPipe
Improving the flow in the pipeline of the next generation of marine biodiscovery scientists (Consiglio Nazionale delle Ricerche - Napoli)


news archive News archive

   © 2010 ALTA S.r.l.u. - Via Fiorentina, 151 - 53100 Siena - Italy
   tel +39 0577 50518    e.mail: info@altaweb.eu
   capitale sociale € 10.845,00
   R.e.a 112828
   C.F. 12364330154 P.IVA 01033520527